Corcept Therapeutics Incorporated competitive analysis

Explore Corcept Therapeutics Incorporated's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 3, 2025Pharmaceutical Formulations Containing Relacorilant, A Heteroaryl-Ketone Fused Azadecalin Compound1

Latest PTAB cases involving Corcept Therapeutics Incorporated

Discover the latest PTAB cases involving Corcept Therapeutics Incorporated, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Corcept Therapeutics Incorporated with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CORCEPT THERAPEUTICS INCORPORATED - 1 - -
ELKINGTON AND FIFE105 - - -